News

Potential game-changer' could save the NHS billions and prevent tens of thousands of heart attacks and strokes ...
The creators of the world-first app at diagnostics company PocDoc say the test could also save the NHS billions ...
A cheap, one-off blood test should be funded in Australia researchers say after a new study showed it could “significantly” ...
THE world’s first smartphone test for type 2 diabetes has launched in the UK. The app-based check is designed to make it ...
HALIFAX, NOVA SCOTIA / ACCESS Newswire / August 26, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received approval from Health Canada for its Reveal® TP (Syphilis) Antibody ...
At-home SMBG typically involves pricking the skin—preferably a fingertip—with a tiny lancet to obtain a drop of blood, which ...
Credit: Lori Chertoff People with rheumatoid arthritis (RA) often have trouble getting out of bed in the morning, let alone ...
Digital health diagnostics firm PocDoc has announced the launch of a smartphone-based test for type 2 diabetes risk.
R&M Healthtech, a Lancaster-based MedTech startup led by Dr Mukesh Kumar, is taking a giant leap forward with its innovative ...
Saliva insulin can differentiate between normal and hyperinsulinemic responses among normoglycemic adults with different body mass index (BMI) classes.
it's a technology that’s giving people a clearer, gentler, and more dynamic way to understand their blood sugar.
With diminished valuations but an unabated will to survive, pandemic-era 'hero' stocks have found other things to do.